Catalent Biologics has deep experience in development, manufacturing, and analytical services for new biological entities, biosimilars, plasmids DNA, cell and gene therapies, vaccines, sterile injectables, mRNA, and antibody-drug conjugates. Catalent has developed 680+ proteins and 16 marketed products using GPEx® technology, manufactured 45+ commercially-approved biotherapeutics, and supported 100+ clinical and commercial cell and gene therapy programs.
With customized solutions, Catalent can scale your program from development to commercial supply, bringing better treatments to patients, faster.
Capabilities include:
• GPEx® cell line development
• SMARTag® bioconjugation
• Expertise in plasmid DNA, viral vector, iPSC, and cell therapy manufacturing
• State-of-the-art biomanufacturing
• Comprehensive analytical services
• Award-winning fill/finish and packaging
With customized solutions, Catalent can scale your program from development to commercial supply, bringing better treatments to patients, faster.
Capabilities include:
• GPEx® cell line development
• SMARTag® bioconjugation
• Expertise in plasmid DNA, viral vector, iPSC, and cell therapy manufacturing
• State-of-the-art biomanufacturing
• Comprehensive analytical services
• Award-winning fill/finish and packaging
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
